Warning: The NCBI web site requires JavaScript to function. more...
Generate a file for use with external citation management software.
Clinical and transcriptional response to the long-acting interleukin-1 blocker canakinumab in Blau syndrome-related uveitis.
Simonini G, Xu Z, Caputo R, De Libero C, Pagnini I, Pascual V, Cimaz R.
Arthritis Rheum. 2013 Feb;65(2):513-8. doi: 10.1002/art.37776.
Related citations
Ocular manifestations of the autoinflammatory syndromes.
Tarabishy AB, Hise AG, Traboulsi EI.
Ophthalmic Genet. 2012 Dec;33(4):179-86. doi: 10.3109/13816810.2012.695421. Epub 2012 Aug 27. Review.
Blau syndrome, clinical and genetic aspects.
Sfriso P, Caso F, Tognon S, Galozzi P, Gava A, Punzi L.
Autoimmun Rev. 2012 Nov;12(1):44-51. doi: 10.1016/j.autrev.2012.07.028. Epub 2012 Aug 2. Review.
Blau arteritis resembling Takayasu disease with a novel NOD2 mutation.
Khubchandani RP, Hasija R, Touitou I, Khemani C, Wouters CH, Rose CD.
J Rheumatol. 2012 Sep;39(9):1888-92. doi: 10.3899/jrheum.120156. Epub 2012 Aug 1.
The innate immune protein Nod2 binds directly to MDP, a bacterial cell wall fragment.
Grimes CL, Ariyananda Lde Z, Melnyk JE, O'Shea EK.
J Am Chem Soc. 2012 Aug 22;134(33):13535-7. doi: 10.1021/ja303883c. Epub 2012 Aug 13.
A case of acute kidney injury with marked hyperuricemia during mizoribine administration.
Nishino T, Shinzato T, Ohta Y, Yamashita H, Obata Y, Shinzato K, Kohno S.
Intern Med. 2012;51(10):1239-43. Epub 2012 May 15.
Pathogen sensing by nucleotide-binding oligomerization domain-containing protein 2 (NOD2) is mediated by direct binding to muramyl dipeptide and ATP.
Mo J, Boyle JP, Howard CB, Monie TP, Davis BK, Duncan JA.
J Biol Chem. 2012 Jun 29;287(27):23057-67. doi: 10.1074/jbc.M112.344283. Epub 2012 May 1.
Ubiquitination and phosphorylation in the regulation of NOD2 signaling and NOD2-mediated disease.
Tigno-Aranjuez JT, Abbott DW.
Biochim Biophys Acta. 2012 Nov;1823(11):2022-8. doi: 10.1016/j.bbamcr.2012.03.017. Epub 2012 Apr 11. Review.
NOD2/CARD15 gene mutation identified in a Chinese family with Blau syndrome.
Xiang H, Zhang T, Chen M, Zhou X, Li Z, Yan N, Li S, Han Y, Gong Q, Liu X.
Mol Vis. 2012;18:617-23. Epub 2012 Mar 9.
Morphologic and immunohistochemical characterization of granulomas in the nucleotide oligomerization domain 2-related disorders Blau syndrome and Crohn disease.
Janssen CE, Rose CD, De Hertogh G, Martin TM, Bader Meunier B, Cimaz R, Harjacek M, Quartier P, Ten Cate R, Thomee C, Desmet VJ, Fischer A, Roskams T, Wouters CH.
J Allergy Clin Immunol. 2012 Apr;129(4):1076-84. doi: 10.1016/j.jaci.2012.02.004.
Rare hereditary autoinflammatory disorders: towards an understanding of critical in vivo inflammatory pathways.
Kanazawa N.
J Dermatol Sci. 2012 Jun;66(3):183-9. doi: 10.1016/j.jdermsci.2012.01.004. Epub 2012 Jan 18. Review.
Miscellaneous non-inflammatory musculoskeletal conditions. Blau syndrome.
Punzi L, Gava A, Galozzi P, Sfriso P.
Best Pract Res Clin Rheumatol. 2011 Oct;25(5):703-14. doi: 10.1016/j.berh.2011.10.017. Review.
Mycobacterium paratuberculosis and autism: is this a trigger?
Dow CT.
Med Hypotheses. 2011 Dec;77(6):977-81. doi: 10.1016/j.mehy.2011.08.024. Epub 2011 Sep 7.
Blau syndrome revisited.
Rose CD, Martin TM, Wouters CH.
Curr Opin Rheumatol. 2011 Sep;23(5):411-8. doi: 10.1097/BOR.0b013e328349c430. Review.
Uveitis in Blau syndrome from a de novo mutation of the NOD2/CARD15 gene.
Raiji VR, Miller MM, Jung LK.
J AAPOS. 2011 Apr;15(2):205-7. doi: 10.1016/j.jaapos.2011.02.004.
The puzzling clinical spectrum and course of juvenile sarcoidosis.
Fretzayas A, Moustaki M, Vougiouka O.
World J Pediatr. 2011 May;7(2):103-10. doi: 10.1007/s12519-011-0261-0. Epub 2011 May 15. Review.
Inhibitor of apoptosis (IAP) proteins in regulation of inflammation and innate immunity.
Damgaard RB, Gyrd-Hansen M.
Discov Med. 2011 Mar;11(58):221-31. Review.
Immunophenotyping in peripheral blood mononuclear cells, aqueous humour and vitreous in a Blau syndrome patient caused by a novel NOD2 mutation.
Jimenez-Martinez MC, Cruz F, Groman-Lupa S, Zenteno JC.
Int J Immunogenet. 2011 Jun;38(3):233-42. doi: 10.1111/j.1744-313X.2011.00998.x. Epub 2011 Feb 15.
Mutational analysis of human NOD1 and NOD2 NACHT domains reveals different modes of activation.
Zurek B, Proell M, Wagner RN, Schwarzenbacher R, Kufer TA.
Innate Immun. 2012 Feb;18(1):100-11. doi: 10.1177/1753425910394002. Epub 2011 Feb 10.
Blau syndrome.
Martin J, Kodjikian L, Duquesne A, Le Scanff J, Sève P.
QJM. 2011 Nov;104(11):997-8. doi: 10.1093/qjmed/hcq188. Epub 2010 Oct 13. No abstract available.
Filters: Manage Filters
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on